OptimizeRx (OPRX) Net Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | OptimizeRx | 101.31 Mn | 81.14 Mn | 15.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.38% |
| Dec 31, 2025 | 35.32% |
| Sep 30, 2025 | 27.80% |
| Jun 30, 2025 | 15.00% |
| Mar 31, 2025 | 23.53% |
| Dec 31, 2024 | 24.11% |
| Sep 30, 2024 | 28.50% |
| Jun 30, 2024 | -14.99% |
| Mar 31, 2024 | 1.67% |
| Dec 31, 2023 | 23.32% |
| Sep 30, 2023 | -40.32% |
| Jun 30, 2023 | -70.23% |
| Mar 31, 2023 | -16.48% |
| Dec 31, 2022 | -192.27% |
| Sep 30, 2022 | -123.31% |
| Jun 30, 2022 | -26.15% |
| Mar 31, 2022 | 73.31% |
| Dec 31, 2021 | 7.04% |
| Sep 30, 2021 | 170.29% |
| Jun 30, 2021 | 145.29% |
| Mar 31, 2021 | 156.41% |
| Dec 31, 2020 | -116.64% |
| Sep 30, 2020 | -68.13% |
| Jun 30, 2020 | -58.85% |
| Mar 31, 2020 | -126.07% |
| Dec 31, 2019 | -127.07% |
| Sep 30, 2019 | -21.80% |
| Jun 30, 2019 | 113.55% |
| Mar 31, 2019 | -15.97% |
| Dec 31, 2018 | -56.20% |
| Sep 30, 2018 | 34.34% |
| Jun 30, 2018 | -30.88% |
| Mar 31, 2018 | -103.06% |
| Dec 31, 2017 | 131.87% |
| Sep 30, 2017 | -27.63% |
| Jun 30, 2017 | -12.60% |
| Mar 31, 2017 | -14.15% |
| Dec 31, 2016 | -55.11% |
| Sep 30, 2016 | -30.81% |
| Jun 30, 2016 | 16.03% |
| Mar 31, 2016 | -38.54% |
| Dec 31, 2015 | -44.03% |
| Sep 30, 2015 | 19.11% |